6.20 USD
↘ 1.05 (14.48%)PRE MARKET (AS OF 07:19 AM EDT)
Apimeds Pharmaceuticals US, Inc.
APUSAMEX • USD
Market: OPEN
Shares of Apimeds Pharmaceuticals US, Inc. (APUS) are trading at $6.20. The stock presents a mixed profile: our models indicate a Buy for technical indicators, while underlying fundamentals flash a Sell. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Sep 25, 2026.
Open?$6.46
High?$6.77
Low?$6.20
Prev. Close?$7.25
Volume?61.5K
Avg. Volume?4.4M
VWAP?$6.42
Rel. Volume?0.01x
Bid / Ask
Bid?$6.35 × 200
Ask?$6.49 × 500
Spread?$0.14
Midpoint?$6.42
Valuation & Ratios
Market Cap?10.9M
Shares Out?1.5M
Float?6.8M
Float %?54.4%
P/E Ratio?N/A
P/B Ratio?0.10
EPS?-$38.55
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Apimeds Pharmaceuticals Us Inc is a development-stage biopharmaceutical company. The Company operates its biopharmaceutical business. Its primary focus is the clinical development of Apitox, a purified honeybee venom-based drug candidate being evaluated for the treatment of pain and inflammation associated with knee osteoarthritis. The Company operates in two segments: the biopharmaceutical segment, which is focused on the clinical development of Apitox through Lokahi, and the digital asset operations segment, which encompasses the holding, sale, and advancement of the MindWaveDAO blockchain and related digital assets through MindWave.
Employees
7
Market Cap
10.9M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2025-05-09
Address
100 MATAWAN RD
MATAWAN, NJ 07747
Phone: 848-201-5010
MATAWAN, NJ 07747
Phone: 848-201-5010
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▲ Bullish(+2/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?100
Piotroski F-Score?0/9Weak
Altman Z-Score?-1.21Distress
Confidence?36%Very Low
Short InterestLow
Short % of Float?0.15%Low
Short Interest?10.3K
Days to Cover?1.0
Free Float6.8M
Avg Daily Volume39.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?0.51Weak
Quick Ratio?0.51Weak
Cash Ratio?0.01Low
Debt/Equity?0.08Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?0.10CHEAP▾
Peers100
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-54.7%WEAK▾
S&P3
ROA?-45.6%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-13332618
Enterprise Value?$19.6M
Fundamentals ratios updated end of day